Correlation Between Arch Biopartners and CHAR Technologies

Can any of the company-specific risk be diversified away by investing in both Arch Biopartners and CHAR Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arch Biopartners and CHAR Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arch Biopartners and CHAR Technologies, you can compare the effects of market volatilities on Arch Biopartners and CHAR Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arch Biopartners with a short position of CHAR Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arch Biopartners and CHAR Technologies.

Diversification Opportunities for Arch Biopartners and CHAR Technologies

0.08

Correlation Coefficient

Arch Biopartners  CHAR Technologies

Significant diversification

The 3 months correlation between Arch and CHAR is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Arch Biopartners and CHAR Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHAR Technologies and Arch Biopartners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arch Biopartners are associated (or correlated) with CHAR Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHAR Technologies has no effect on the direction of Arch Biopartners i.e., Arch Biopartners and CHAR Technologies go up and down completely randomly.

Pair Corralation between Arch Biopartners and CHAR Technologies

Assuming the 90 days trading horizon Arch Biopartners is expected to generate 0.53 times more return on investment than CHAR Technologies. However, Arch Biopartners is 1.88 times less risky than CHAR Technologies. It trades about 0.03 of its potential returns per unit of risk. CHAR Technologies is currently generating about -0.03 per unit of risk. If you would invest  190.00  in Arch Biopartners on October 5, 2024 and sell it today you would earn a total of  4.00  from holding Arch Biopartners or generate 2.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Arch Biopartners  vs.  CHAR Technologies

Arch Biopartners

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arch Biopartners are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable fundamental indicators, Arch Biopartners is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

CHAR Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CHAR Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Arch Biopartners and CHAR Technologies

The main advantage of trading using opposite Arch Biopartners and CHAR Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arch Biopartners position performs unexpectedly, CHAR Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHAR Technologies will offset losses from the drop in CHAR Technologies' long position.

The idea behind Arch Biopartners and CHAR Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.